Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Accounts Payables: 2011-2024

Historic Accounts Payables for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $7.4 million.

  • Mimedx Group's Accounts Payables rose 64.86% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 64.86%. This contributed to the annual value of $7.4 million for FY2024, which is 18.11% down from last year.
  • According to the latest figures from FY2024, Mimedx Group's Accounts Payables is $7.4 million, which was down 18.11% from $9.0 million recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Accounts Payables peaked at $9.0 million during FY2023, and registered a low of $7.4 million during FY2021.
  • Moreover, its 3-year median value for Accounts Payables was $8.5 million (2022), whereas its average is $8.3 million.
  • As far as peak fluctuations go, Mimedx Group's Accounts Payables grew by 14.48% in 2022, and later decreased by 18.11% in 2024.
  • Over the past 5 years, Mimedx Group's Accounts Payables (Yearly) stood at $8.8 million in 2020, then decreased by 15.74% to $7.4 million in 2021, then rose by 14.48% to $8.5 million in 2022, then grew by 7.03% to $9.0 million in 2023, then fell by 18.11% to $7.4 million in 2024.